Arcus Biosciences, Inc. (RCUS)

Arcus Biosciences Stock Forecast

Stock Price Forecast

According to 12 analysts polled by S&P Global, Arcus Biosciences stock has a consensus rating of "Buy" and an average price target of $34.82. The average 1-year stock price forecast is 48.61% higher than the current stock price, while the lowest is $22 (-6.10%) and the highest is $47 (+100.60%).

Price Target: $34.82 (+48.61%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$22	$34.82	$34	$47
Change	-6.10%	+48.61%	+45.11%	+100.60%

Analyst Ratings

The average analyst rating for Arcus Biosciences stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	3	4	4	4	4	5
Buy	3	2	1	2	3	2
Hold	2	3	4	4	4	4
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	8	9	9	10	11	11

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Supawat Thongthip Truist Securities	Truist Securities	Strong Buy Initiates $30 → $35	Strong Buy	Initiates	$30 → $35	+49.38%	May 18, 2026
Terence Flynn Morgan Stanley	Morgan Stanley	Hold Maintains $20 → $22	Hold	Maintains	$20 → $22	-6.10%	May 11, 2026
Richard Law Goldman Sachs	Goldman Sachs	Strong Buy Maintains $30 → $34	Strong Buy	Maintains	$30 → $34	+45.11%	May 7, 2026
Robert Driscoll Wedbush	Wedbush	Buy Maintains $37 → $41	Buy	Maintains	$37 → $41	+74.99%	Apr 2, 2026
Yigal Nochomovitz Citigroup	Citigroup	Strong Buy Maintains $44 → $45	Strong Buy	Maintains	$44 → $45	+92.06%	Mar 5, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

91.20M

Decreased by -63.08%

from 247.00M

Revenue Next Year

134.88M

Increased by 47.89%

from 91.20M

EPS This Year

-3.89

from -3.29

EPS Next Year

-3.25

from -3.89

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	383.00M	112.00M	117.00M	258.00M	247.00M	91.20M	134.88M
Revenue Growth	391.03%	-70.76%	4.46%	120.51%	-4.26%	-63.08%	47.89%
EPS	0.71	-3.71	-4.15	-3.14	-3.29	-3.89	-3.25
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	13	13

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028	2029	2030	2031	2032	2033
High	231.0M	372.2M
Avg	91.2M	134.9M
Low	6.9M	n/a

Revenue Growth

Revenue Growth	2026	2027	2028	2029	2030	2031	2032	2033
High	-6.5%	308.1%
Avg	-63.1%	47.9%
Low	-97.2%	-

EPS Forecast

EPS	2026	2027	2028	2029	2030	2031	2032	2033
High	-2.85	-2.14
Avg	-3.89	-3.25
Low	-5.10	-3.79

EPS Growth

EPS Growth	2026	2027	2028	2029	2030	2031	2032	2033
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.